...
Abortion Clinics Near Me

Monthly Archives: May, 2025

  1. Abortion Services: Expanding Access, Elevating Care

    As access to abortion care continues to be challenged across the U.S., raising abortion services is more critical than ever. This means not only expanding the number of clinics and providers but also elevating the quality, reach, and inclusivity of abortion care for everyone who needs it. Expanding Access Raising abortion services starts with access….

  2. Global Perspectives on Abortion: How the U.S. Compares Worldwide

    Global Perspectives on Abortion: How the U.S. Compares Worldwide As abortion rights face unprecedented threats in the United States, it’s critical to examine how America’s policies compare internationally. The global landscape reveals stark contrasts—from nations treating abortion as essential healthcare to those imposing near-total bans. This analysis draws on the Center for Reproductive Rights data…

  3. Spring Holidays and Reproductive Rights: Unexpected Connections

    Spring Holidays and Reproductive Rights: Unexpected Connections   While April brings holidays focused on renewal and reflection, abortion clinics face a stark reality: reproductive rights are under unprecedented attack. As many celebrate Easter, Passover, and Earth Day this month, we examine the often-overlooked ties between these traditions and the fight for bodily autonomy—plus how clinics…

ABORTION RELATED FEEDS & POSTS

RSS NAF

  • NAF’s New Look
    Dear Community,  I’m excited to share that later this week, NAF will officially launch a newly refreshed brand identity and website, both designed to better reflect who we are today and what we aspire to be in the future. With this new look, we’re aiming to pay homage to our radical roots, with a nod… […]
  • National Abortion Federation Statement on FDA Review of Mifepristone
    FOR IMMEDIATE RELEASE September 25, 2025 CONTACT: Carina Pacheco, naf@berlinrosen.com  NATIONAL — Following the release of a letter from HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Martin Makary in which they confirmed that the FDA is conducting a “review” of mifepristone based on a junk science report from an anti-abortion think tank, Brittany Fonteno, President & CEO… […]

PRESERVE ABORTION